...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: VP of clinical operations

"With 14 clinical trials (12 active, 1 not yet recruiting, and 1 suspended) for zen 3694"

All for a measly share price of (more or less) 20 cents US on the OTC exchange! Go figure!

 

Koo

Share
New Message
Please login to post a reply